(Q48378854)

11 February 2018

title

Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis (English)

1 reference

11 February 2018

relapsing-remitting multiple sclerosis

main subject

0 references

0 references

4

1 reference

11 February 2018

Christopher R Tench

series ordinal

3

object named as

Christopher R Tench

1 reference

11 February 2018

author name string

Francesco Zellini

series ordinal

1

1 reference

11 February 2018

Graham Niepel

series ordinal

2

1 reference

11 February 2018

publication date

7 December 2009

1 reference

11 February 2018

Multiple Sclerosis Journal

published in

1 reference

11 February 2018

volume

15

1 reference

11 February 2018

issue

12

1 reference

11 February 2018

page(s)

1442-1449

1 reference

11 February 2018

The human hypothalamus in metabolic and episodic disorders.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

The fornix and mammillary bodies in older adults with Alzheimer's disease, mild cognitive impairment, and cognitive complaints: a volumetric MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

The relationship of sleep disturbances and fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Excessive muscular fatigue in patients with spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement--EEG evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Cytokine-induced sickness behaviour: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Neuroendocrine aspects of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Multislice T1 relaxation time measurements in the brain using IR-EPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Deep gray matter and fatigue in MS: a T1 relaxation time study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Disability rating scales in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis--a quantitative T1 relaxation time mapping approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Paroxysmal hypothermia as a clinical feature of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Twenty years of research on cytokine-induced sickness behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350306

21 January 2018

Identifiers

DOI

10.1177/1352458509350306

1 reference

11 February 2018

1 reference

11 February 2018